Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Delta inulin-based adjuvants promote the generation of polyfunctional CD4+ T cell responses and protection against Mycobacterium tuberculosis infection
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-08-11
DOI
10.1038/s41598-017-09119-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Human Phase 1 trial of low-dose inactivated seasonal influenza vaccine formulated with Advax™ delta inulin adjuvant
- (2016) David L. Gordon et al. VACCINE
- Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice
- (2016) Claudio Counoupas et al. npj Vaccines
- Different human vaccine adjuvants promote distinct antigen-independent immunological signatures tailored to different pathogens
- (2016) Niels Peter H. Knudsen et al. Scientific Reports
- Alzheimer’s disease AdvaxCpG- adjuvanted MultiTEP-based dual and single vaccines induce high-titer antibodies against various forms of tau and Aβ pathological molecules
- (2016) Hayk Davtyan et al. Scientific Reports
- Advax™, a novel microcrystalline polysaccharide particle engineered from delta inulin, provides robust adjuvant potency together with tolerability and safety
- (2015) Nikolai Petrovsky et al. VACCINE
- A gold glyco-nanoparticle carrying a listeriolysin O peptide and formulated with Advax™ delta inulin adjuvant induces robust T-cell protection against listeria infection
- (2015) Estela Rodriguez-Del Rio et al. VACCINE
- Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy
- (2014) Eleonora G. Thacher et al. AIDS
- Advax-Adjuvanted Recombinant Protective Antigen Provides Protection against Inhalational Anthrax That Is Further Enhanced by Addition of Murabutide Adjuvant
- (2014) Brandon Feinen et al. Clinical and Vaccine Immunology
- Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect againstMycobacterium tuberculosisinfection
- (2014) Manuela Flórido et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Beyond macrophages: the diversity of mononuclear cells in tuberculosis
- (2014) Smita Srivastava et al. IMMUNOLOGICAL REVIEWS
- The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells
- (2014) A. Seubert et al. JOURNAL OF IMMUNOLOGY
- TLR4 Ligands Lipopolysaccharide and Monophosphoryl Lipid A Differentially Regulate Effector and Memory CD8+ T Cell Differentiation
- (2014) W. Cui et al. JOURNAL OF IMMUNOLOGY
- Severe Acute Respiratory Syndrome-Associated Coronavirus Vaccines Formulated with Delta Inulin Adjuvants Provide Enhanced Protection while Ameliorating Lung Eosinophilic Immunopathology
- (2014) Yoshikazu Honda-Okubo et al. JOURNAL OF VIROLOGY
- Immunogenicity and safety of Advax™, a novel polysaccharide adjuvant based on delta inulin, when formulated with hepatitis B surface antigen: A randomized controlled Phase 1 study
- (2014) David Gordon et al. VACCINE
- Unexpected Role for IL-17 in Protective Immunity against Hypervirulent Mycobacterium tuberculosis HN878 Infection
- (2014) Radha Gopal et al. PLoS Pathogens
- Progress in tuberculosis vaccine development and host-directed therapies—a state of the art review
- (2014) Stefan H E Kaufmann et al. Lancet Respiratory Medicine
- Minimal Differentiation of Classical Monocytes as They Survey Steady-State Tissues and Transport Antigen to Lymph Nodes
- (2013) Claudia Jakubzick et al. IMMUNITY
- Control of Chronic Mycobacterium tuberculosis Infection by CD4 KLRG1- IL-2-Secreting Central Memory Cells
- (2013) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- JE-ADVAX Vaccine Protection against Japanese Encephalitis Virus Mediated by Memory B Cells in the Absence of CD8+ T Cells and Pre-Exposure Neutralizing Antibody
- (2013) M. Larena et al. JOURNAL OF VIROLOGY
- An Inactivated Cell Culture Japanese Encephalitis Vaccine (JE-ADVAX) Formulated with Delta Inulin Adjuvant Provides Robust Heterologous Protection against West Nile Encephalitis via Cross-Protective Memory B Cells and Neutralizing Antibody
- (2013) N. Petrovsky et al. JOURNAL OF VIROLOGY
- Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial
- (2013) Michele D Tameris et al. LANCET
- A novel hepatitis B vaccine containing Advax™, a polysaccharide adjuvant derived from delta inulin, induces robust humoral and cellular immunity with minimal reactogenicity in preclinical testing
- (2013) Fadi Saade et al. VACCINE
- The Importance of Adjuvant Formulation in the Development of a Tuberculosis Vaccine
- (2012) S. L. Baldwin et al. JOURNAL OF IMMUNOLOGY
- Synchronization of Dendritic Cell Activation and Antigen Exposure Is Required for the Induction of Th1/Th17 Responses
- (2012) A. T. Kamath et al. JOURNAL OF IMMUNOLOGY
- Intravital multiphoton imaging of immune responses in the mouse ear skin
- (2012) Jackson LiangYao Li et al. Nature Protocols
- High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants
- (2012) Xinyuan Chen et al. VACCINE
- Randomized clinical trial of immunogenicity and safety of a recombinant H1N1/2009 pandemic influenza vaccine containing Advax™ polysaccharide adjuvant
- (2012) David L. Gordon et al. VACCINE
- Advax™, a polysaccharide adjuvant derived from delta inulin, provides improved influenza vaccine protection through broad-based enhancement of adaptive immune responses
- (2012) Yoshikazu Honda-Okubo et al. VACCINE
- Cutaneous immunosurveillance by self-renewing dermal γδ T cells
- (2011) Nital Sumaria et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Recombinant BCG ΔureC hly+ Induces Superior Protection Over Parental BCG by Stimulating a Balanced Combination of Type 1 and Type 17 Cytokine Responses
- (2011) Christiane Desel et al. JOURNAL OF INFECTIOUS DISEASES
- A multistage tuberculosis vaccine that confers efficient protection before and after exposure
- (2011) Claus Aagaard et al. NATURE MEDICINE
- Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes
- (2011) Samuele Calabro et al. VACCINE
- Delta inulin polysaccharide adjuvant enhances the ability of split-virion H5N1 vaccine to protect against lethal challenge in ferrets
- (2011) R. Colby Layton et al. VACCINE
- Specific T Cell Frequency and Cytokine Expression Profile Do Not Correlate with Protection against Tuberculosis after Bacillus Calmette-Guérin Vaccination of Newborns
- (2010) Benjamin M. N. Kagina et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Delta inulin: a novel, immunologically active, stable packing structure comprising -D-[2 -> 1] poly(fructo-furanosyl) -D-glucose polymers
- (2010) P. D. Cooper et al. GLYCOBIOLOGY
- Vaccine Adjuvants: Putting Innate Immunity to Work
- (2010) Robert L. Coffman et al. IMMUNITY
- Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection withMycobacterium tuberculosis
- (2010) Andrea Cruz et al. JOURNAL OF EXPERIMENTAL MEDICINE
- An inactivated Vero cell-grown Japanese encephalitis vaccine formulated with Advax, a novel inulin-based adjuvant, induces protective neutralizing antibody against homologous and heterologous flaviviruses
- (2010) M. Lobigs et al. JOURNAL OF GENERAL VIROLOGY
- Induction of mucosal and systemic antibody and T-cell responses following prime-boost immunization with novel adjuvanted human immunodeficiency virus-1-vaccine formulations
- (2010) A. D. Cristillo et al. JOURNAL OF GENERAL VIROLOGY
- Neutrophils Influence the Level of Antigen Presentation during the Immune Response to Protein Antigens in Adjuvants
- (2010) C.-W. Yang et al. JOURNAL OF IMMUNOLOGY
- A Defined Tuberculosis Vaccine Candidate Boosts BCG and Protects Against Multidrug-Resistant Mycobacterium tuberculosis
- (2010) S. Bertholet et al. Science Translational Medicine
- Ag85B–ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in naïve human volunteers
- (2010) Jaap T. van Dissel et al. VACCINE
- T-helper 1 and T-helper 2 adjuvants induce distinct differences in the magnitude, quality and kinetics of the early inflammatory response at the site of injection
- (2009) Karen Smith Korsholm et al. IMMUNOLOGY
- Liposomes based on dimethyldioctadecylammonium promote a depot effect and enhance immunogenicity of soluble antigen
- (2009) Malou Henriksen-Lacey et al. JOURNAL OF CONTROLLED RELEASE
- Antigen Load Governs the Differential Priming of CD8 T Cells in Response to the Bacille Calmette Guerin Vaccine or Mycobacterium tuberculosis Infection
- (2009) A. A. Ryan et al. JOURNAL OF IMMUNOLOGY
- Tuberculosis Subunit Vaccination Provides Long-Term Protective Immunity Characterized by Multifunctional CD4 Memory T Cells
- (2009) T. Lindenstrom et al. JOURNAL OF IMMUNOLOGY
- Tuberculosis vaccine development: goals, immunological design, and evaluation
- (2008) Daniel F Hoft LANCET
- Cationic Liposomes Formulated with Synthetic Mycobacterial Cordfactor (CAF01): A Versatile Adjuvant for Vaccines with Different Immunological Requirements
- (2008) Else Marie Agger et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started